Literature DB >> 12558342

The contribution of transfusion to HCV infection in England.

K Soldan1, M Ramsay, A Robinson, H Harris, N Anderson, E Caffrey, C Chapman, A Dike, G Gabra, A Gorman, A Herborn, P Hewitt, N Hewson, D A Jones, C Llewelyn, E Love, V Muddu, V Martlew, A Townley.   

Abstract

The English HCV lookback programme has identified some individuals with transfusion-transmitted HCV infection. The path from the collection of donations from HCV-infected donors to the identification of infected recipients was constructed. The probability of different outcomes at each branch was derived from data collected during this programme. This path of probabilities was then used to produce a complete estimate of the number of recipients infected by blood transfusions (dead and alive at the end of 1995) by re-entry of blood components that fell out of the lookback at various steps prior to recipient testing, and entry of components from HCV-infected donations that were never identified for lookback. Less than 14,000 recipients were estimated to have been infected with HCV during the decade prior to the start of donation testing. Over 60% of these were expected to have died by the end of 1995. Transfusion has infected a large group of individuals. However, this group constitutes a very small, and declining, proportion of all HCV infections in the population.

Entities:  

Mesh:

Year:  2002        PMID: 12558342      PMCID: PMC2869921          DOI: 10.1017/s0950268802007744

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  6 in total

1.  Sentinel laboratory surveillance of hepatitis C antibody testing in England: understanding the epidemiology of HCV infection.

Authors:  L J Brant; M Hurrelle; M A Balogun; P Klapper; F Ahmad; E Boxall; A Hale; V Hollyoak; I B Ibrahim; W Irving; R Meigh; K J Mutton; B C Patel; W K Paver; S Pugh; C Taylor; A J Turner; M E Ramsay
Journal:  Epidemiol Infect       Date:  2006-07-13       Impact factor: 2.451

2.  Improved hepatitis C treatment response in younger patients: findings from the UK HCV National Register cohort study.

Authors:  H E Harris; A Costella; G Amirthalingam; G Alexander; M E B Ramsay; N Andrews
Journal:  Epidemiol Infect       Date:  2011-11-29       Impact factor: 2.451

Review 3.  Surveillance of transfusion-transmissible infections comparison of systems in five developed countries.

Authors:  Sheila F O'Brien; Shimian Zou; Syria Laperche; Lisa J Brant; Clive R Seed; Steven H Kleinman
Journal:  Transfus Med Rev       Date:  2011-09-25

4.  Most common genotypes and risk factors for HCV in Gaza strip: a cross sectional study.

Authors:  Basim M Ayesh; Sofia S Zourob; Salah Y Abu-Jadallah; Yonat Shemer-Avni
Journal:  Virol J       Date:  2009-07-16       Impact factor: 4.099

5.  Antiretroviral therapy and liver disease progression in HIV and hepatitis C co-infected patients: a systematic review and meta-analysis.

Authors:  Alexis Llewellyn; Mark Simmonds; Will L Irving; Ginny Brunton; Amanda J Sowden
Journal:  Hepatol Med Policy       Date:  2016-08-15

6.  Transmission of viral hepatitis through blood transfusion in Sweden, 1968 to 2012.

Authors:  Viktor Dahl; Ammar Majeed; Agneta Wikman; Rut Norda; Gustaf Edgren
Journal:  Euro Surveill       Date:  2020-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.